Aberrant somatic hypermutation in tumor cells of nodular-lymphocyte-predominant and classic Hodgkin lymphoma

Blood
Arcangelo LisoB Falini

Abstract

Aberrant somatic hypermutation (SHM) has been identified as a mechanism for genomewide instability in diffuse large B-cell lymphoma (DLBCL). To assess whether aberrant SHM plays a role in the molecular pathogenesis of Hodgkin lymphoma (HL), we investigated microdissected neoplastic cells of nodular lymphocyte-predominant HL (NLPHL; n = 10) and classic HL (cHL; n = 9) for the presence of mutations in the 5' sequences of 4 previously identified aberrant SHM targets (PIM1, PAX5, RhoH/TTF, c-MYC). Mutations in one or more genes were detected in 80% of NLPHLs and 55% of cHLs, with 50% and 30% of patients carrying mutations in 2 or more genes, respectively. The most frequently involved protooncogene was PAX5, mutated in 7 of 9 patients with NLPHL and 2 of 9 patients with cHL. In total, 34 mutations were detected in NLPHL (frequency, 1.04/1,000 bp) and 35 were detected in patients with cHL (frequency, 1.92/1,000 bp). Mutations were of somatic origin because they were absent in control T cells and shared most of the features of the immunoglobulin variable (IGV) gene-associated SHM mechanism-ie, single nucleotide substitutions (n = 63) with rare deletions/insertions (n = 6) and a predominance of transitions over transversions with prefe...Continue Reading

Citations

Apr 29, 2010·Current Hematologic Malignancy Reports·Harald Stein, Roshanak Bob
Nov 17, 2009·Cell Death and Differentiation·K NihiraK Yoshida
Dec 15, 2010·Nature Reviews. Cancer·Martijn C NawijnAnton Berns
Apr 30, 2009·Annual Review of Pathology·Roland SchmitzRalf Küppers
Oct 1, 2008·Cell Communication and Signaling : CCS·Florian Fueller, Katharina F Kubatzky
Jul 17, 2013·Diagnostic Pathology·Ewelina Szczepanek-ParulskaMarek Ruchala
Aug 10, 2010·Core Evidence·Paul RichardsonKenneth Anderson
Feb 9, 2010·Haematologica·Jose A Martinez-ClimentFelipe Prosper
Jan 22, 2011·Advances in Hematology·Pier Paolo PiccalugaStefano A Pileri
May 15, 2013·Human Pathology·Stefano A Pileri
Aug 20, 2011·Seminars in Diagnostic Pathology·Alessandro PileriStefano A Pileri
Jan 9, 2009·Leukemia Research·Davide Rossi
Oct 16, 2007·The Journal of Pathology·S TedoldiT Marafioti
May 12, 2011·Hematological Oncology·Antonino CarboneArmando Santoro
Mar 22, 2014·Clinical Lymphoma, Myeloma & Leukemia·Anupama GoelMichael L Grossbard
Apr 16, 2015·Genome Medicine·Janice M SpenceW Richard Burack
Oct 28, 2016·International Journal of Cancer. Journal International Du Cancer·Antonino CarboneRiccardo Dolcetti
Dec 7, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·William Bensinger
Mar 31, 2010·Nature Reviews. Clinical Oncology·Heinz Ludwig, Niklas Zojer
Jun 7, 2008·Expert Review of Anticancer Therapy·Patrizia FalcoAntonio Palumbo
Nov 8, 2012·Oncotarget·Alireza Hadj KhodabakhshiSteven J M Jones
Mar 17, 2007·Cancer Research·Michelle L DuquetteNancy Maizels
Feb 14, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Asher A Chanan-KhanMeletios A Dimopoulos
Feb 12, 2021·Cancers·Magdalena M BruneAlexandar Tzankov

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.